BackOncternal Therapeutics Overview

Oncternal Therapeutics EBIT

EBIT (Earnings Before Interest and Taxes) analysis for ONCT.

Quarterly EBIT

-$8.68M
↑ 17.05% YoY

As of Sep 30, 2024

Annual EBIT (TTM)

-$54.37M
↓ 23.18% YoY

Trailing 12 months ending Sep 30, 2024

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin